Dialysis patients are highly venerable to Severe Acute Respiratory Syndrome (SARS-CoV-2) due to comorbidity conditions. In this facility-based cross-sectional study, 111 hemodialysis patients were enrolled from April, 2020 to July, 2021. Social and hospital characteristics of patient’s data are abstracted from medical records, and descriptive, binominal and multinomial logistic regression was demonstrated to test association using statistical packages for social science. Among 111 hemodialysis patients Fifty three, 47.7% (53/111) patients during the study period were under the confirmed clinical presentation of a global pandemic of SARS-CoV-2 infection. In this presented studies, inpatient hospitalization, transit of hospitals, hypertension were the most frequent clinical characteristics dependent on COVID-19 infection in dialysis patients at three referral hospitals in Addis Ababa, Ethiopia. The findings from the study indicated that dialysis patients are vournariable group of the population more likely to infect with COVID-19. Overall epidemiology of covid-19 in dialysis patients was 47%; this indicates hospitalized dialysis is highly exposed to the current global outback. Inpatient clients and patients transferred from another hospital mostly presented comorbid conditions associated with the prevalence.

1. W. H. Organization, “WHO COVID-19 preparedness and response progress report-1 february to 30 june 2020,” Geneva, Switzerland: World Health Organization, Tech. Rep., 2020.
2. R. Wang, C. Liao, H. He, C. Hu, Z. Wei, Z. Hong, C. Zhang, M. Liao, and H. Shui, “COVID-19 in hemodialysis patients: A report of 5 cases,” American Journal of Kidney Diseases, vol. 76, no. 1, pp. 141–143, 2020. doi: https://doi.org/10.1053/j.ajkd.2020.03.009
3. N. Canpolat et al., “Covid-19 in pediatric patients undergoing chronic dialysis and kidney transplantation,” European Journal of Pediatrics, vol. 181, no. 1, pp. 117–123, 2022. doi: https://doi.org/10.1007/s00431-021-04191-z
4. T. J. Kakkanattu, S. Sankarasubbaiyan, A. K. Yadav, M. Kundu, M. G. Bg, V. Kumar, K. Shah, and V. Jha, “Outcome and determinants of outcome of COVID-19 infection among hemodialysis patients: Findings from a national dialysis network program in India,” Kidney International Reports, vol. 6, no. 5, pp. 1429–1432, 2021. doi: https://doi.org/10.1016/j.ekir.2021.03.003
5. E. D. Weinhandl, J. B. Wetmore, Y. Peng, J. Liu, D. T. Gilbertson, and K. L. Johansen, “Initial effects of COVID-19 on patients with ESKD,” Journal of the American Society of Nephrology, vol. 32, no. 6, pp. 1444–1453, 2021. doi: https://doi.org/10.1681/ASN.2021010009
6. W. H. Organization et al., “Covid-19 weekly epidemiological update,” Geneva, Switzerland: World Health Organization, Tech. Rep., 2022.
7. E. Hoxha, A. Suling, J. E. Turner, M. Haubitz, J. Floege, T. B. Huber, and J.-C. Galle, “COVID19 prevalence and mortality in chronic dialysis patients,” Deutsches Ärzteblatt International, vol. 118, no. 11, pp. 195–196, 2021. doi: https://doi.org/10.3238/arztebl.m2021.0160
8. C. Clarke et al., “High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening,” Journal of the American Society of Nephrology, vol. 31, no. 9, pp. 1969–1975, 2020. doi: https://doi.org/10.1681/ASN.2020060827
9. W. Shang, Y. Li, H. Li, W. Li, C. Li, Y. Cai, and J. Dong, “Correlation between laboratory parameters on admission and outcome of COVID19 in maintenance hemodialysis patients,” International Urology and Nephrology, vol. 53, no. 1, pp. 165–169, 2021. doi: https://doi.org/10.1007/s11255-020-02646-0
10. S. Alizon, S. Haim-Boukobza, V. Foulongne, L. Verdurme, S. Trombert-Paolantoni, E. Lecorche, B. Roquebert, and M. T. Sofonea, “Rapid spread of the SARS-CoV-2 delta variant in some french regions, june 2021,” Eurosurveillance, vol. 26, no. 28, p. 2100573, 2021. doi: https://doi.org/10.2807/1560-7917.ES.2021.26.28.2100573
11. T. A. Ikizler, “COVID-19 and dialysis units: What do we know now and what should we do?” American Journal of Kidney Diseases, vol. 76, no. 1, pp. 1–3, 2020. doi: https://doi.org/10.1053/j.ajkd.2020.03.008
12.  A. M. Valeri, S. Y. Robbins-Juarez, J. S. Stevens, W. Ahn, M. K. Rao, J. Radhakrishnan, A. G. Gharavi, S. Mohan, and S. A. Husain, “Presentation and outcomes of patients with ESKD and COVID19,” Journal of the American Society of Nephrology, vol. 31, no. 7, pp. 1409–1415, 2020. doi: https://doi.org/10.1681/ASN.2020040470
13. Y. Ma, B. Diao, X. Lv, J. Zhu, C. Chen, L. Liu, S. Zhang, B. Shen, and H. Wang, “Epidemiological, clinical, and immunological features of a cluster of COVID-19-contracted hemodialysis patients,” Kidney International Reports, vol. 5, no. 8, pp. 1333–1341, 2020. doi: https://doi.org/10.1016/j.ekir.2020.06.003
14. R. W. Corbett, S. Blakey, D. Nitsch, M. Loucaidou, A. McLean, N. Duncan, D. R. Ashby et al., “Epidemiology of COVID-19 in an urban dialysis center,” Journal of the American Society of Nephrology, vol. 31, no. 8, pp. 1815–1823, 2020. doi: https://doi.org/10.1681/ASN.2020040534
15. M. Albalate et al., “High prevalence of asymptomatic COVID-19 in hemodialysis. daily learning during first month of COVID-19 pandemic,” Nefrología (English Edition), vol. 40, no. 3, pp. 279–286, 2020. doi: https://doi.org/10.1016/j.nefroe.2020.06.013

S. T. Yirga, B. Aklilu, M. Yohannes, and M. Hailhu, “Incidence of Severe Acute Respiratory Syndrome (Covid-19) on maintenance hemodialysis patients in some hospitals dialysis centers in Addis Ababa, Ethiopia,” International Journal of Health and Medical Sciences, vol. 8, pp. 6-11, 2022. doi: https://dx.doi.org/10.20469/ijhms.8.30002